27.09.2017
- Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...
04.09.2017
- US drugmaker Gilead Sciences has agreed to pay almost $12 billion to acquire compatriot Kite Pharma. Through the cash transaction, it will gain access to Car-T, Kite’s cutting-edge...
13.01.2017
- American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...
08.09.2016
- Global brand agency Interbrand has identified the top 10 pharmaceutical brands among the top 25 global pharmaceutical companies. Besides the financial value of the brand, its...
05.09.2016
- Gilead Sciences is once again preparing to defend itself against a challenge to its hepatitis C intellectual property. The latest lawsuit comes from the University of Minnesota...
22.08.2016
- Pfizer has won the race for biotech firm Medivation. The US drugs giant has agreed to pay about $14 billion in a move that adds leading prostate cancer drug Xtandi to its portfolio...
26.07.2016
- Drugmakers who supply Medicare, the US health insurance for the elderly, are raking in billions of dollars for “pricey medications” at taxpayer expense, a report by the news agency...
04.07.2016
- The US Food and Drug Administration has approved Gilead Sciences’ combination pill Epclusa, the first to treat all major forms of hepatitis C. This is the latest in a series of...
